Fortitude Advisory Group L.L.C. Harvard Bioscience Inc Transaction History

Fortitude Advisory Group L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 16, 2022	SELL	$3.28 - $6.42 $1,640 - $3,210	-500 Closed	0 $0
Q4 2021 May 20, 2022	BUY	$6.37 - $8.18 $3,185 - $4,090	500 New	500 $4,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.